About
Partner and Patent Attorney at Mewburn Ellis LLP specializing in EPO oppositions and appeals and advising on European prosecution and divisional strategies for life sciences patent families, including work on the CRISPR/Cas platform. Katherine qualified as a Chartered and European Patent Attorney in 2010, joined Mewburn Ellis in 2006 and became a partner in 2014.
Practice areas
Intellectual PropertyPatent Prosecution & LitigationLife Sciences
Office
Expertise
EPO oppositions and appealsEuropean prosecution strategiesDivisional strategy for opposed patentsCRISPR/CasGene therapyAAV (adeno-associated virus)Recombinant antibody engineeringPurification and formulation techniques for biological therapeuticsTherapeutic use claims (modes of administration, dosage regimens)
Education
- Degree in Biochemistry and Molecular Biology, University of Cambridge
- PhD, University of Cambridge (Medical Research Council’s Mitochondrial Biology Unit)
Admissions
- Chartered Patent Attorney (2010)
- European Patent Attorney (2010)